Upgrade for detailed insurance, legislation, and other documents analytics for individual cases; real-time analysis of the datasets from your EHR, CRM, ERP, or other software; and more Enterprise Features.
This HCPCS code represents 10 mg of atezolizumab (Tecentriq), a monoclonal antibody administered intravenously for treating various cancers, including bladder cancer.
2025 HCPCS code J9072
This HCPCS code represents 5 mg of cyclophosphamide from Dr. Reddy's, a cancer medication typically administered intravenously.
2025 HCPCS code J9267
This HCPCS code represents the supply of 1 mg of paclitaxel for intravenous administration.
2025 HCPCS code J9130
Dacarbazine, 100 mg; this HCPCS code represents the supply of the drug only, not its administration.
2025 HCPCS code J9296
This HCPCS code represents 10 mg of pemetrexed (from Accord), a drug used to treat mesothelioma or non-squamous, non-small cell lung cancer.
2025 HCPCS code J9065
HCPCS code J9065 represents the drug cladribine, priced per milligram (mg).
2025 HCPCS code J9321
Injection, epcoritamab-bysp, 0.16 mg.
2025 HCPCS code J9371
Vincristine sulfate liposome, injection, 1 mg
2025 HCPCS code J9057
Injection, copanlisib, 1 mg
2025 HCPCS code J9210
Injection, emapalumab-lzsg, 1 mg
2025 HCPCS code J9075
Injection, cyclophosphamide, not otherwise specified, 5 mg.
2025 HCPCS code J9317
Injection, sacituzumab govitecan-hziy, 2.5 mg
2025 HCPCS code J9098
Injection, cytarabine liposome, 10 mg.
2025 HCPCS code J9270
Injection, plicamycin, 2.5 mg
2025 HCPCS code J9074
Injection, cyclophosphamide (sandoz), 5 mg
2025 HCPCS code J9298
Injection, nivolumab and relatlimab-rmbw, 3 mg/1 mg.
2025 HCPCS code J9030
BCG live intravesical instillation; 1 mg.
2025 HCPCS code J9313
One unit of J9313 represents 0.01 mg of moxetumomab pasudotox-tdfk administered intravenously to treat relapsed or refractory hairy cell leukemia in adults.
2025 HCPCS code J9355
J9355 represents 10 mg of trastuzumab (excluding biosimilars) for intravenous infusion; it inhibits cancer cell multiplication and spread.
2025 HCPCS code J9333
This HCPCS code represents 1 mg of rozanolixizumab-noli, a drug administered subcutaneously to treat generalized myasthenia gravis.
2025 HCPCS code J9393
Injection, fulvestrant (Teva), 25 mg; not therapeutically equivalent to J9395.
2025 HCPCS code J9332
Injection, efgartigimod alfa-fcab, 2 mg.
2025 HCPCS code J9357
Valrubicin, intravesical, 200 mg injection.
2025 HCPCS code J9055
Injection, cetuximab, 10 mg.
2025 HCPCS code J9227
This HCPCS code represents 10 mg of isatuximab-irfc, a monoclonal antibody administered intravenously, typically used in multiple myeloma treatment.
2025 HCPCS code J9228
Injection, ipilimumab, 1 mg.
2025 HCPCS code J9306
J9306 represents 1 mg of pertuzumab injection.
2025 HCPCS code J9155
Degarelix injection, up to 1 mg.
2025 HCPCS code J9036
This code represents 1 mg of bendamustine hydrochloride (Belrapzo) administered intravenously.
2025 HCPCS code J9309
This HCPCS code represents 1 mg of polatuzumab vedotin-piiq administered intravenously.
2025 HCPCS code J9050
This HCPCS code represents the supply of 100 mg of carmustine, a chemotherapy drug used to inhibit cancer cell growth.Administration is not included.
2025 HCPCS code J9172
This HCPCS code represents 1 mg of docetaxel (Ingenus), a chemotherapy drug administered intravenously for various cancers.
2025 HCPCS code J9219
Leuprolide acetate implant, 65 mg; a hormonal therapy drug used to treat advanced prostate cancer.
2025 HCPCS code J9205
J9205 represents 1 mg of irinotecan liposome injection, used in treating pancreatic adenocarcinoma.
2025 HCPCS code J9308
This HCPCS code represents 5 mg of the chemotherapy drug ramucirumab, a medication used to inhibit cancer cell growth and spread.It covers only the drug itself, not its administration.
2025 HCPCS code J9258
Paclitaxel protein-bound particles (Teva), 1 mg; not therapeutically equivalent to J9264.
2025 HCPCS code J9302
Injection of ofatumumab, 10 mg.
2025 HCPCS code J9393
<a href="../medical-coding/reference/J9395" target="_blank" title="Medical Code J9395 2025">Tiêm, fulvestrant (Teva), 25 mg; không tương đương điều trị với J9395.</a>
2025 HCPCS code J9358
Injection, fam-trastuzumab deruxtecan-nxki, 1 mg.
2025 HCPCS code J9376
Injection, pozelimab-bbfg, 1 mg
2025 HCPCS code J9352
This HCPCS code represents the supply of 0.1 mg of trabectedin, a chemotherapy drug used to treat certain types of sarcoma.
2025 HCPCS code J9171
This HCPCS code represents 1 mg of the chemotherapy drug docetaxel for injection.
2025 HCPCS code J9325
Injection, talimogene laherparepvec, per 1 million plaque-forming units.
2025 HCPCS code J9196
200 mg of gemcitabine hydrochloride (Accord), administered intravenously for various cancers.
2025 HCPCS code J9263
This HCPCS code represents 0.5 mg of oxaliplatin for injection.It covers only the drug, not its administration.
2025 HCPCS code J9203
One unit represents 0.1 mg of gemtuzumab ozogamicin for IV injection in treating AML.
2025 HCPCS code J9301
Injection, obinutuzumab, 10 mg.
2025 HCPCS code J9248
This HCPCS code represents 1 mg of melphalan (Hepzato™), administered intravenously for liver cancer therapy.
2025 HCPCS code J9019
Injection of asparaginase (Erwinaze), 1,000 IU.
2025 HCPCS code J9266
This HCPCS code represents a single-dose vial of pegaspargase, a chemotherapy medication used to inhibit cancer cell growth.
Continue with Personal Account
Thank you for exploring iFrame ♥ Please subscribe for unlimited access to our top-tier AI model, which directly supports our dedicated knowledge creators maintaining an ad-free internet experience.